Studies on mice with experimental MI and diabetes have demonstrated that the CB1-pathway is implicated in cardiomyocyte overgrowth, whereas CB2-signalling is associated with protection against cardiac hypertrophy [4, 5, 8]. Here, CNR1 is linked to diabetes mellitus.